mail2

Spectrum Library

Optic neuritis at disease onset predicts poor visual outcome in neuromyelitis optica spectrum disorders

Multiple Sclerosis and Related Disorders Volume 41, June 2020, 102045

Juliana MSS. Amaral Natália Talim Rodrigo Kleinpaul Marco A. Lana-Peixotoon behalf of the Brazilian Committee for Treatment and Research in Multiple Sclerosis

Abstract
Introduction
Optic neuritis (ON) in neuromyelitis optica spectrum disorders (NMOSD) may occur at the onset of the disease, during relapse attacks, or both. It is well known that ON in NMOSD may cause permanent visual disability, but the influence of the time of its occurrence has not been investigated.

Objective
We evaluated the effect of the time of ON occurrence on visual outcome in a cohort of NMOSD patients.

Methods
We retrospectively analyzed the medical records of NMOSD patients with ON who met the 2015 International consensus criteria for NMOSD diagnosis. We assessed demographic and clinical data, the Expanded Disability Status Scale (EDSS), and visual disability according to the scores of the Kurtzke Visual Function Scale (KVS) and Wingerchuk’s Optic Nerve Impairment Scale (WONIS). We divided patients into three groups according to the time of ON occurrence: (1) ON at disease onset; (2) ON exclusively in relapse attacks; and (3) ON at both disease onset and in relapse attacks.

Results
Out of 187 patients with suspected NMOSD, 85 (42.4%) met the inclusion criteria. ON occurred exclusively at the disease onset in 16 (18.8%) patients, exclusively in relapse attacks in 43 (50.6%) patients, and at both the onset and in relapse attacks in 26 (30.6%) patients. There was no significant difference in the EDSS scores of the groups. In comparison with patients with ON exclusively occurring during relapse attacks, patients with ON at disease onset had higher KVS scores (p = 0.009) and WONIS scores (p = 0.005). Patients with ON at both onset and in relapses had a larger number of ON attacks and NMOSD relapses, as well as the poorest visual outcome.

Conclusions
ON at disease onset is a predictive factor for poor visual outcome in NMOSD patients.